FIBRINOLYTIC AGENTS IN TREATMENT OF TOTAL HYPHEMA AND SECONDARY GLAUCOMA.
D000293:Adolescent; D000818:Animals; D000867:Anterior Chamber; D002648:Child; D003850:Deoxyribonuclease I; D004358:Drug Therapy; D005131:Eye Injuries; D005341:Fibrinolysin; D005343:Fibrinolytic Agents; D005901:Glaucoma; D006801:Humans; D006988:Hyphema; D007793:Lagomorpha; D010600:Pharmacology; D011817:Rabbits; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D014116:Toxicology
D005343:Fibrinolytic Agents; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin
ADOLESCENCE; ANTERIOR CHAMBER; CHILD; DRUG THERAPY; EYE INJURIES; FIBRINOLYSIN; GLAUCOMA; HYPHEMA; PHARMACOLOGY; RABBITS; STREPTODORNASE AND STREPTOKINASE; TOXICOLOGIC REPORT